Dr. Dorigo is the Director of Stanford Obstetrics and Gynecology in the Division of Gynecologic Oncology and the Director of the Stanford Gynecologic Oncology Clinical Care Program.  Current clinical trials include A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer and Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment.